Related Experiment Videos
Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies
1University of Colorado Cancer Center, Division of Medical Oncology and Lung Cancer Program, Denver 80262, USA.
Seminars in Oncology
|June 13, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Lung cancer research and treatment: global perspectives and strategic calls to action.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).
Annals of oncology : official journal of the European Society for Medical Oncology·2009
EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2007
Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.
Seminars in oncology·2026
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.
Seminars in oncology·2026
Dual alexithymia: A relational framework for clinical communication in oncology.
Seminars in oncology·2026
SPIB as a context-specific regulator in cancer: from molecular mechanisms to clinical implications.
Seminars in oncology·2026